DEA’s 2020 Rule Opened the Door to Better Cannabis Research
How the 2020 DEA rule diversifies federally funded cannabis research, boosting study quality with broader, standardized, and more representative supplies.
How the 2020 DEA rule diversifies federally funded cannabis research, boosting study quality with broader, standardized, and more representative supplies.
Dab pens offer portability for medical cannabis but dosing isn't precise; learn the risks, potency, and safest use with professional guidance.
New EEG study hints full-spectrum cannabis may elicit stronger brain responses than high-purity THC, fueling the ongoing entourage effect debate.
Mesothelioma symptom relief may come from cannabis-based medicines, but they are not a cure—use under medical guidance for nausea, pain, sleep and appetite.
USDA regulators weigh in on a genetically engineered hemp study, signaling a shifting regulatory landscape for GM cannabis, with permits and compliance in focus
Unlock predictable cannabis edibles with safe decarboxylation: how heat converts THCA/CBDA, explore oven, sous-vide, and safety tips for consistent potency.
New Ontario study challenges hype of a post-legalization cannabis surge, showing no broad rise and nuanced patterns by prior use.
Alberta study links cannabis use disorder to higher cardiovascular risk; an observational finding highlighting potential risks for clinicians and patients.
ANA recognizes cannabis nursing as a specialty, advancing education, evidence-based practice, and nurses' guidance while clarifying scope and safety.
Discover how NMR fingerprinting speeds cannabis authentication-classifying extracts by full-spectrum chemistry with high accuracy and streamlined testing.